Related Experiment Video
Updated: Aug 9, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon-gamma has immunomodulatory effects with minor endocrine and metabolic effects in humans
J de Metz1, F Sprangers, E Endert
1Department of Endocrinology and Metabolism, The Netherlands. j.demetz@amc.uva.nl
Insights
Interferon-gamma (IFN-gamma) minimally impacts endocrine and metabolic systems. This immune signaling molecule does not appear to be a primary mediator in the complex interplay between immune and metabolic pathways.
Area of Science:
- Immunology
- Endocrinology
- Metabolism
Background:
- The interaction between the immune and endocrine systems is crucial for maintaining homeostasis.
- Interferon-gamma (IFN-gamma) is a key cytokine in immune responses, but its role in neuroendocrine regulation is not fully understood.
Purpose of the Study:
- To investigate the in vivo effects of recombinant human interferon-gamma (IFN-gamma) on endocrine and metabolic parameters in healthy subjects.
- To determine if IFN-gamma modulates the interaction between the immune and endocrine systems.
Main Methods:
- A placebo-controlled crossover study involving six healthy volunteers.
- Administration of recombinant human IFN-gamma or saline, followed by measurements of glucose appearance rate (using [6,6-2H2]glucose infusion) and resting energy expenditure (indirect calorimetry).
- Analysis of immune markers (HLA-DR, neopterin, IL-6, TNF-alpha) and hormonal levels (ACTH, cortisol, GH, epinephrine, insulin, C-peptide, glucagon, IGF-I).
Main Results:
- IFN-gamma administration significantly increased monocyte HLA-DR expression, serum neopterin, and IL-6 levels.
- Plasma concentrations of ACTH and cortisol were elevated post-IFN-gamma administration (P < 0.05).
- IFN-gamma significantly increased resting energy expenditure but did not affect glucose metabolism, free fatty acids, or other measured hormones.
Conclusions:
- Interferon-gamma acts as a minor stimulator of specific endocrine and metabolic pathways.
- IFN-gamma alone is unlikely to be a major mediator in the interaction between the immune and endocrine/metabolic systems.
Abstract:
To evaluate whether interferon-gamma (IFN-gamma) is involved in the interaction between the immune and endocrine systems in vivo, we studied six healthy subjects twice in a placebo-controlled trial: once after administration of recombinant human IFN-gamma and, on another occasion, after administration of saline. The rate of appearance of glucose was determined by infusion of [6,6-2H2]glucose and resting energy expenditure by indirect calorimetry. Human leukocyte antigen-DR gene expression on monocytes and serum neopterin increased after administration of IFN-gamma (P < 0.05 vs. control). IFN-gamma increased serum interleukin-6 levels significantly. Levels of tumor necrosis factor-alpha remained below detection limits. IFN-gamma increased plasma concentrations of ACTH and cortisol (P < 0.05 vs. control), IFN-gamma did not alter concentrations of growth hormone, (nor)epinephrine, insulin, C peptide, glucagon, or insulin-like growth factor I. IFN-gamma did not alter plasma concentrations of glucose and free fatty acids nor the rate of appearance of glucose. IFN-gamma increased resting energy expenditure significantly. We conclude that IFN-gamma is a minor stimulator of the endocrine and metabolic pathways. Therefore, IFN-gamma by itself is probably not a major mediator in the interaction between the immune and the endocrine and metabolic systems.
Related Concept Videos
Endocrine Signaling
Biological Effects of Radiation
Endocrine Signaling
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

